Increased bovine Tim-3 and its ligand expressions during bovine leukemia virus infection

Veterinary Research

Volumn 43, Issue 1, 2012, Pages

  Okagawa, Tomohiro ^a   Konnai, Satoru ^a   Ikebuchi, Ryoyo ^a   Suzuki, Saori ^a   Shirai, Tatsuya ^a   Sunden, Yuji ^a   Onuma, Misao ^a   Murata, Shiro ^a   Ohashi, Kazuhiko ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BOS; BOVINAE; BOVINE LEUKEMIA VIRUS;

COMPLEMENTARY DNA; GALECTIN; MEMBRANE PROTEIN; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE LEUKEMIA VIRUS; CATTLE; CATTLE DISEASE; ENZOOTIC BOVINE LEUKOSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; PHYLOGENY; PHYSIOLOGY; VIROLOGY; VIRUS LOAD;

AMINO ACID SEQUENCE; ANIMALS; CATTLE; CATTLE DISEASES; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ENZOOTIC BOVINE LEUKOSIS; GALECTINS; GENE EXPRESSION REGULATION; LEUKEMIA VIRUS, BOVINE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, MESSENGER; VIRAL LOAD;

EID: 84866429647     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-43-45     Document Type: Article

References (38)

1. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA, Science 2007 318 1141 1143 10.1126/science.1148536 18006747
2. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao D, Liu Y, Zhu F, Zhang L, Sun W, Liang X, Gao L, Ma C, J Hepatol 2010 52 322 329 10.1016/j.jhep.2009.12.005 20133006
3. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, Kuchroo VK, Nature 2002 415 536 541 10.1038/415536a 11823861
4. The TIM gene family: emerging roles in immunity and disease. Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ, Nat Rev Immunol 2003 3 454 462 10.1038/nri1111 12776205
5. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK, Nat Immunol 2005 6 1245 1252 10.1038/ni1271 16286920
6. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkins disease. Türeci O, Schmitt H, Fadle N, Pfreundschuh M, Sahin U, J Biol Chem 1997 272 6416 6422 10.1074/jbc.272.10.6416 9045665
7. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. Wada J, Kanwar YS, J Biol Chem 1997 272 6078 6086 10.1074/jbc.272.9.6078 9038233
8. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Hastings WD, Anderson DE, Kassam N, Koguchi K, Greenfield EA, Kent SC, Zheng XX, Strom TB, Hafler DA, Kuchroo VK, Eur J Immunol 2009 39 2492 2501 10.1002/eji.200939274 19676072
9. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez-Fueyo A, Zheng XX, Coyle AJ, Strom TB, Freeman GJ, Kuchroo VK, Nat Immunol 2003 4 1102 1110 10.1038/ni988 14556006
10. Restoring function in exhausted CD8 T cells during chronic viral infection. Barber DL, Wherry EJ, Masopust D, Zhu BG, Allison JP, Sharpe AH, Freeman GJ, Ahmed R, Nature 2006 439 682 687 10.1038/nature04444 16382236
11. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Nat Immunol 2009 10 29 37 10.1038/ni.1679 19043418
12. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu BG, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJR, Klenerman P, Ahmed R, Freeman GJ, Walker BD, Nature 2006 443 350 354 10.1038/nature05115 16921384
13. PD-1 and its ligands in tolerance and immunity. Keir ME, Butte MJ, Freeman GJ, Sharpel AH, Annu Rev Immunol 2008 26 677 704 10.1146/annurev. immunol.26.021607.090331 18173375
14. T cell exhaustion. Wherry EJ, Nat Immunol 2011 6 492 499
15. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, Freeman GJ, Kuchroo VK, Ahmed R, Proc Natl Acad Sci U S A 2010 107 14733 14738 10.1073/pnas.1009731107 20679213
16. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue FY, Kovacs C, Sassi A, Loutfy M, Halpenny R, Persad D, Spotts G, Hecht FM, Chun TW, McCune JM, Kaul R, Rini JM, Nixon DF, Ostrowski MA, J Exp Med 2008 205 2763 2779 10.1084/jem.20081398 19001139
17. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ, Castelblanco N, Kuchroo V, Gretch DR, Rosen HR, J Virol 2009 83 9122 9130 10.1128/JVI.00639-09 19587053
18. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR, Rosen HR, J Clin Invest 2010 120 4546 4557 10.1172/JCI43127 21084749
19. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. Fourcade J, Sun Z, Benallaoua M, Guillaume P, Luescher IF, Sander C, Kirkwood JM, Kuchroo V, Zarour HM, J Exp Med 2010 207 2175 2186 10.1084/jem.20100637 20819923
20. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinskikh E, Busson P, Polyak SJ, Hirashima M, Rosen HR, PLoS One 2010 5 9504 10.1371/journal.pone.0009504 20209097
21. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Gillet N, Florins A, Boxus M, Burteau C, Nigro A, Vandermeers F, Balon H, Bouzar AB, Defoiche J, Burny A, Reichert M, Kettmann R, Willems L, Retrovirology 2007 4 18 10.1186/1742-4690-4- 18 17362524
22. Molecular cloning and expression analysis of bovine programmed death-1. Ikebuchi R, Konnai S, Sunden Y, Onuma M, Ohashi K, Microbiol Immunol 2010 54 291 298 20536726
23. Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade. Ikebuchi R, Konnai S, Shirai T, Sunden Y, Murata S, Onuma M, Ohashi K, Vet Res 2011 42 103 10.1186/1297-9716-42-103 21943148
24. Molecular cloning of bovine lymphocyte activation gene-3 and its expression characteristics in bovine leukemia virus-infected cattle. Shirai T, Konnai S, Ikebuchi R, Okagawa T, Suzuki S, Sunden Y, Onuma M, Murata S, Ohashi K, Vet Immunol Immunopathol 2011 144 462 467 10.1016/j.vetimm.2011.08.018 21981995
25. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S, Mol Biol Evol 2011 28 2731 2739 10.1093/molbev/msr121 21546353
26. The rapid quantitative analysis of bovine cytokine genes by real-time RT-PCR. Konnai S, Usui T, Ohashi K, Onuma M, Vet Microbiol 2003 94 283 294 10.1016/S0378-1135(03)00119-6 12829382
27. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Niwa H, Yamamura K, Miyazaki J, Gene 1991 108 193 199 10.1016/0378-1119(91)90434-D 1660837
28. Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. Yokomizo T, Kato K, Hagiya H, Izumi T, Shimizu T, J Biol Chem 2001 276 12454 12459 10.1074/jbc.M011361200 11278893
29. Helix 8 of the leukotriene B4 receptor is required for the conformational change to the low affinity state after G-protein activation. Okuno T, Ago H, Terawaki K, Miyano M, Shimizu T, Yokomizo T, J Biol Chem 2003 278 41500 41509 10.1074/jbc.M307335200 12902330
30. The costimulatory role of TIM molecules. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, Umetsu DT, Immunol Rev 2009 229 259 270 10.1111/j.1600-065X.2009. 00772.x 19426227
31. Host immune responses in the course of bovine leukemia virus infection. Kabeya H, Ohashi K, Onuma M, J Vet Med Sci 2001 63 703 708 10.1292/jvms.63.703 11503896
32. Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins. Orlik O, Splitter GA, J Virol 1996 70 7584 7593 8892878
33. Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus. Pyeon D, OReilly KL, Splitter GA, J Virol 1996 70 5706 5710 8764093
34. Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis. Pyeon D, Splitter GA, J Virol 1998 72 6917 6921 9658146
35. Regulation of galectin-9 expression and release in Jurkat T cell line cells. Chabot S, Kashio Y, Seki M, Shirato Y, Nakamura K, Nishi N, Nakamura T, Matsumoto R, Hirashima M, Glycobiology 2002 12 111 118 10.1093/glycob/12.2.111 11886844
36. Galectin-9 in physiological and pathological conditions. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T, Saita N, Nakamura T, Glycoconj J 2004 19 593 600 14758084
37. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Wang F, Wan L, Zhang C, Zheng X, Li J, Chen ZK, Immunobiology 2009 214 342 349 10.1016/j.imbio.2008.10.007 19362679
38. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC, J Exp Med 2010 207 2187 2194 10.1084/jem.20100643 20819927